Psychiatry Research
Volume 129, Issue 1 , Pages 29-37 , 30 November 2004

Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes

  • Doug Hyun Han

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +82-33-260-3207; fax: +82-33-260-3212.
    • Department of Psychiatry, Chun-cheon National Hospital, Won chang Lee, Dong San Myun, Chun-cheon, Kang won, 200-843, South Korea
    • ,
  • Doo Byung Park

      Affiliations

    • Department of Psychiatry, School of Medicine Chung-Ang University, Pil dong, Jung Gu, Seoul, 100-272, South Korea
    • ,
  • Chul Na

      Affiliations

    • Department of Psychiatry, School of Medicine Chung-Ang University, Pil dong, Jung Gu, Seoul, 100-272, South Korea
    • ,
  • Baik Seok Kee

      Affiliations

    • Department of Psychiatry, School of Medicine Chung-Ang University, Pil dong, Jung Gu, Seoul, 100-272, South Korea
    • ,
  • Young Sik Lee

      Affiliations

    • Department of Psychiatry, School of Medicine Chung-Ang University, Pil dong, Jung Gu, Seoul, 100-272, South Korea

Received 7 July 2003 ,Revised 6 May 2004 ,Accepted 16 June 2004.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: Author; 1994;
  2. Apter A, Gothelf D, Orbach I, Weizman R, Ratzoni G, Har-Even D, et al. Correlation of suicidal and violent behavior in different diagnostic categories in hospitalized adolescent patients. Journal of the American Academy of Child and Adolescent Psychiatry. 1995;34:912–918
  3. Åsberg M, Träskman L, Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Archives of General Psychiatry. 1976;33:1193–1197
  4. Bonnet-Brilhault F, Laurent C, Thibaut F, Campion D, Chavand O, Samolyk D, et al. Serotonin transporter gene polymorphism and schizophrenia: an association study. Biological Psychiatry. 1997;42:634–636
  5. Brennan PA, Mednick SA, Jacobsen B. Assessing the role of genetics in crime using adoption cohorts. Ciba Foundation Symposium. 1996;194:115–123
  6. Cadoret RJ, Yates WR, Troughton E, Woodworth G, Stewart MA. Genetic-environmental interaction in the genesis of aggressivity and conduct disorders. Archives of General Psychiatry. 1995;52:916–924
  7. Cairns RB. Aggression from a development perspective: genes, environments and interactions. Ciba Foundation Symposium. 1996;194:45–56
  8. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pourin S, et al. Aggressive behavior and altered amount of brain serotonin and norepinephrine in mice lacking MAOA. Science. 1995;268:1763–1766
  9. Chen CH, Lee YR, Wci FC, Koong FJ, Hwu HG, Hsiao KJ. Association study of NIaIII and Mspl genetic polymorphism of catecholamine-O-methyltransferase gene and susceptibility to schizophrenia. Biological Psychiatry. 1997;41:985–987
  10. Cohen J, Braver T, Brown J. Computational perspectives on dopamine function in prefrontal cortex. Curr. Opin. Neurobiol. 2002;12:223–229
  11. Collier DA, Sober G, Li T, Heils A, Catalano M, Di Bella D, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Molecular Psychiatry. 1996;1:453–460
  12. Cortet P, Baud P, Abbar M, Boulenger LP, Castelnau D, Mouthon D, et al. Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene. Molecular Psychiatry. 2001;6:338–341
  13. Danielle LS, Pollock BG, Robert AS, Benoit HM, Jules R, William EK, et al. The 5-HTTPRS/L Polymorphism and Aggressive Behavior in Alzheimer Disease. Archives of Neurol. 2001;58:1425–1428
  14. Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, Murphy KC, et al. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity. American Journal of Psychiatry. 1996;153:268–270
  15. De Chaldee M, Corbex M, Campion D, Jay M, Samolyk D, Petit T, et al. No evidence for linkage between COMT and schizophrenic French population. Psychiatry Research. 2001;102:87–90
  16. Durstewitz D, Seamans JK. The computational role of dopamine D1 receptors in working memory. Neural Networks. 2002;15:561–572
  17. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceeding of the National Academy of Sciences of the United States of America. 2001;12:6917–6922
  18. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry. 1978;35:837–844
  19. Geijer T, Frisch A, Persson ML, Wasserman D, Rockah R, Michaelovsky E, et al. Search for association between suicide attempt and serotonergic polymorphisms. Psychiatric Genetics. 2000;10:19–26
  20. Gogos JA, Morgan M, Kuine V, Santha M, Ogawa S, Pfaff D, et al. Catecholamine-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceeding of the National Academy of Sciences of the United States of America. 1998;95:9991–9996
  21. Grace AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience Letters. 1991;41:1–24
  22. Heils A, Teufel A, Petri S, Seeman M, Bengel D, Balling U, et al. Functional polymorphism within the promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. Journal of Neural Transmission. 1995;102:247–254
  23. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, et al. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry. 1996;66:2621–2624
  24. Hilakivi-Clarke LA, Goldberg R. Effects of tryptophan and serotonin uptake inhibitors on behavior in male transgenic transforming growth factor alpha mice. European Journal of Pharmacology. 1993;237:101–108
  25. Jentsch JD, Tran A, Le D, Youngren KD, Roth RH. Suchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology. 1997;17:92–99
  26. Jones G, Zammit S, Norton N, Hamshere ML, Jones SJ, Milham C, et al. Aggression behavior in patients with schizophrenia is associated with catechol-O-methyltransferase genotype. British Journal of Psychiatry. 2001;1790:351–355
  27. Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG. Serotonin transporter gene polymorphism and antidepressant response. NeuroReport. 2000;11:215–219
  28. König M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, et al. Pain responses, anxiety and aggression in mice deficient in preproenkephalin. Nature. 1996;383:535–538
  29. Kotler M, Barak P, Cohen H, Averbuch CE, Grinspoon A, Gritsenko I, et al. Homicidal behavior in schizophrenia associated with genetic polymorphism determinig low catechol-O-methyl transferase (COMT) activity. American Journal of Medical Genetics. 1999;88:628–633
  30. Kotler M, Barak P, Cohen H, Averbuch IE, Grinspoon A, Gritsenko I, et al. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol-O-methyltransferase (COMT) activity. American Journal of Medical Genetics. 1999;88:233–628
  31. Kouri EM, Lukas SE, Pope HG, Oliva PS. Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug and Alcohol Dependence. 1995;40:73–79
  32. Kunz M, Sikora J, Krakowski M, Convit A, Cooper TB, Volavka J. Serotonin in violent patients with schizophrenia. Psychiatry Research. 1995;59:161–163
  33. Lachman H, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243–250
  34. Lachman H, Nolan KA, Mohr P, Saito T, Volavka J. Association between catechol-O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. American Journal of Psychiatry. 1998;155:835–837
  35. Lee JH, Hong TK, Hyun DS. Possible association between serotonin transporter promoter region polymorphism and impulsivity in Koreas. Psychiatry Research. 2003;118:19–24
  36. Lesch KP, Wolozin BL, Estler HC, Murphy DL, Riederer P. Isolation of a cDNA encoding the human brain serotonin transporter. Journal of Neural Transmission. 1993;91:67–72
  37. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulation region. Science. 1996;274:1527–1531
  38. Malhotra AK, Goldman D, Mazzani C, Clifton A, Breier A, Pickar D. A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Molecular Psychiatry. 1998;3:328–332
  39. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. American Journal of Psychiatry. 2002;159:652–654
  40. Miles DR, Carey G. Genetic and environmental architecture of human aggression. Journal of Personality and Social Psychology. 1997;72:207–217
  41. Moore H, West AR, Grace AA. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biological Psychiatry. 1999;46:40–55
  42. Nolan KA, Bilder RM, Lachman HM, Volavka J. Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. American Journal of Psychiatry. 2004;161:359–361
  43. Ohmori O, Shinkai T, Kojima H, Terao T, Suzuki T, Mita T, et al. Association study of a functional study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neuroscience Letters. 1998;243:109–112
  44. Pae CU, Kim JJ, Lee SJ, Lee CU, Lee C, Paik IH, et al. Polymorphism of the serotonin transporter gene and symptomatic dimensions of schizophrenia in the Korean population. Neuropsychobiology. 2003;47:182–186
  45. Park TW, Yoon KS, Kim JH, Park WY, Ari H, Kang DH. Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia. European Neuropsychopharmacology. 2002;12:299–303
  46. Philippu G, Hoo JJ, Milech U, Argarwall DP, Schrappe O, Goedde HW. Catechol-O-methyltransferase of erythrocytes in patients with endogenous psychoses. Psychiatry Research. 1981;4:139–146
  47. Plutchik R, Van Praag HM. A self-report measure of violence risk, II. Comprehensive Psychiatry. 1990;31:450–456
  48. Rao D, Jönsson EG, Paus S, Ganguli R, Nöthen M, Nimgoonkar VL. Schizophrenia and the serotonin transporter gene. Psychiatric Genetics. 1998;8:207–212
  49. Robert AS, Pollock BG, Danielle LS, Mulsant BH, Rosen J, William E, et al. The 5-HTTPR Polymorphism Confers Liability to a Combined Phenotype of Psychotic and Aggressive Behavior in Alzheimer disease. International Psychogeriatrics. 2001;13:401–409
  50. Russ MJ, Lachman HM, Kashdan T, Saito T, Bajmakovic-Kacila S. Analysis of catechol-O-methyltransferase and 5-hydroxytryptamine transporter polymorphism in patients at risk for suicide. Psychiatry Research. 2000;93:73–78
  51. Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA, et al. d,l-Fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology. 1999;88:83–87
  52. Shishkina GT, Borodin PM, Naumenko EB. The noradrenaline content and the alpha 2-adrenoreceptor count in the brain of brown rats selected for the absence of aggressive behavior in relation to man. Zhurnal Vysshei Nervnoi Deyatel'nosti Imeni I.P. Pavlova. 1990;40:326–333
  53. Steinert T, Wiebe C, Gebhardt RP. Aggressive behavior against self and others among first admission patients with schizophrenia. Psychiatric Services. 1999;50:85–90
  54. Strous RD, Bark M, Parsia SS, Volavka J, Lachman HM. Analysis of functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for associations with aggressive and antisocial behaviour. Psychiatry Research. 1997;69:71–77
  55. Strous RD, Nolan KA, Lapidus R, Diaz L, Saito T, Lachman HM. Aggressive behavior in schizophrenia is associated with the low activity COMT polymorphism. American Journal of Medical Genetics. 2003;120:29–34
  56. Swanson JW, Holtzer CE, Ganju VK, Jono RT. Violence and psychiatric disorder in the community: evidence from the Epidemiology Catchment Area Surveys. Hospital and Community Psychiatry. 1990;41:761–770
  57. Tecott LH, Barondes SH. Genes and aggressiveness: behavioral genetics. Current Biology. 1996;6:238–240
  58. Tsai SJ, Hong CJ, Yu YW, Lin CH, Song HL, Lai HC, et al. Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Schizophrenia Research. 2000;44:177–181
  59. Yudofski SC, Silver JM, Jackson W. The Overt Aggression Scale for the objective rating of verbal and physical aggression. American Journal of Psychiatry. 1986;143:35–39
  60. Zalsman G, Frisch A, Bromberg M, Gelernter J, Michaelovsky E, Campino A, et al. Family-based association study of serotonin transporter promoter in suicidal adolescents. American Journal of Medical Genetics. 2001;105:239–245

PII: S0165-1781(04)00170-2

doi: 10.1016/j.psychres.2004.06.013

Psychiatry Research
Volume 129, Issue 1 , Pages 29-37 , 30 November 2004

Article Tools